Translational Psychiatry
Papers 2791
1 page of 280 pages (2,791 results)
#1Maria Goldberg (German Center for Neurodegenerative Diseases)H-Index: 1
#2Rezaul Islam (German Center for Neurodegenerative Diseases)H-Index: 6
Last. Andrea Schmitt (USP: University of São Paulo)H-Index: 39
view all 13 authors...
MicroRNAs have been linked to synaptic plasticity and memory function and are emerging as potential biomarkers and therapeutic targets for cognitive diseases. Most of these data stem from the analysis of model systems or postmortem tissue from patients which mainly represents an advanced stage of pathology. Due to the in-accessibility of human brain tissue upon experimental manipulation, it is still challenging to identify microRNAs relevant to human cognition, which is however a key step for fu...
#1Miklos ArgyelanH-Index: 23
#2Todd LenczH-Index: 85
Last. Georgios PetridesH-Index: 33
view all 11 authors...
Electroconvulsive therapy (ECT) is of the most effective treatments available for treatment-resistant depression, yet it is underutilized in part due to its reputation of causing cognitive side effects in a significant number of patients. Despite intensive neuroimaging research on ECT in the past two decades, the underlying neurobiological correlates of cognitive side effects remain elusive. Because the primary ECT-related cognitive deficit is memory impairment, it has been suggested that the hi...
#1Emiliano Tesoro-Cruz (Mexican Social Security Institute)H-Index: 9
#2Leticia Manuel-Apolinar (Mexican Social Security Institute)H-Index: 13
Last. Miguel Pérez de la Mora (UNAM: National Autonomous University of Mexico)H-Index: 19
view all 10 authors...
Tryptophan hydroxylase type 2 (Tph2) is the rate-limiting enzyme for serotonin (5-HT) biosynthesis in the brain. Dysfunctional Tph2 alters 5-HT biosynthesis, leading to a deficiency of 5-HT, which could have repercussions on human behavior. In the last decade, several studies have associated polymorphisms of the TPH2 gene with suicidal behavior. Additionally, a 5-HT deficiency has been implicated in various psychiatric pathologies, including alcoholism, impulsive behavior, anxiety, and depressio...
#2Meng LiH-Index: 48
Last. Ian H. Gotlib (Stanford University)H-Index: 136
view all 32 authors...
Major depressive disorder (MDD) is associated with abnormal neural circuitry. It can be measured by assessing functional connectivity (FC) at resting-state functional MRI, that may help identifying neural markers of MDD and provide further efficient diagnosis and monitor treatment outcomes. The main aim of the present study is to investigate, in an unbiased way, functional alterations in patients with MDD using a large multi-center dataset from the PsyMRI consortium including 1546 participants f...
#1Jeremiah Joyce (Mayo Clinic)H-Index: 1
#2Caroline Grant (Mayo Clinic)
Last. Thomas J. Carmody (UTSW: University of Texas Southwestern Medical Center)H-Index: 39
view all 16 authors...
Combination antidepressant pharmacotherapies are frequently used to treat major depressive disorder (MDD). However, there is no evidence that machine learning approaches combining multi-omics measures (e.g., genomics and plasma metabolomics) can achieve clinically meaningful predictions of outcomes to combination pharmacotherapy. This study examined data from 264 MDD outpatients treated with citalopram or escitalopram in the Mayo Clinic Pharmacogenomics Research Network Antidepressant Medication...
#1Lajos KatonaH-Index: 2
#2István Bitter (Semmelweis University)H-Index: 41
Last. Pál Czobor (Semmelweis University)H-Index: 65
view all 3 authors...
Randomized controlled trials (RCTs) have been considered as gold standard for establishing the efficacy and safety of investigational new drugs; nonetheless, the generalizability of their findings has been questioned. To address this issue, an increasing number of naturalistic studies and real-world database analyses have been conducted. The question of how much information from these two approaches is congruent or discrepant with each other is of great importance for the clinical practice. To a...
#1Catherine R. Virelli (U of T: University of Toronto)
#2Ayeshah G. Mohiuddin (U of T: University of Toronto)H-Index: 1
Last. James L. Kennedy (CAMH: Centre for Addiction and Mental Health)H-Index: 124
view all 3 authors...
Pharmacogenomics (PGx) is the study of genetic influences on an individual’s response to medications. Improvements in the quality and quantity of PGx research over the past two decades have enabled the establishment of commercial markets for PGx tests. Nevertheless, PGx testing has yet to be adopted as a routine practice in clinical care. Accordingly, policy regulating the commercialization and reimbursement of PGx testing is in its infancy. Several papers have been published on the topic of cha...
#1Wenting Fang (Fujian Medical University)H-Index: 4
#2Naian Xiao (Ha Tai: Xiamen University)
Last. Jing Zhang (Fujian Medical University)H-Index: 19
view all 9 authors...
Population-based studies reveal that apolipoprotein E (APOE) e4 gene allele is closely associated with late-life depression (LLD). However, its exact role and underlying mechanism remain obscure. The current study found that aged apoE4-targeted replacement (TR) mice displayed obvious depression-like behavior when compared with age-matched apoE3-TR mice. Furthermore, apoE4 increased stress-induced depression-like behaviors, accompanied by declines in the hippocampal 5-HT (1A) radioligand [18F] MP...
#1Alyssa R Roeckner (Emory University)
#2Katelyn I. Oliver (Emory University)
Last. Jennifer S. Stevens (Emory University)H-Index: 22
view all 5 authors...
Resilience in the face of major life stressors is changeable over time and with experience. Accordingly, differing sets of neurobiological factors may contribute to an adaptive stress response before, during, and after the stressor. Longitudinal studies are therefore particularly effective in answering questions about the determinants of resilience. Here we provide an overview of the rapidly-growing body of longitudinal neuroimaging research on stress resilience. Despite lingering gaps and limit...
#1Angharad N de Cates (Oxford Health NHS Foundation Trust)H-Index: 7
#2Lucy Wright (Oxford Health NHS Foundation Trust)H-Index: 8
Last. Susannah E. Murphy (Oxford Health NHS Foundation Trust)H-Index: 20
view all 9 authors...
Cognitive deficits commonly accompany psychiatric disorders but are often underrecognised, and difficult to treat. The 5-HT4 receptor is a promising potential treatment target for cognitive impairment because in animal studies 5-HT4 receptor agonists enhance hippocampal-dependent memory processes. To date, there has been little work translating these effects to humans. We tested whether short-term administration of the 5-HT4 partial agonist, prucalopride, modified behavioural and neural (fMRI) m...
Top fields of study
Developmental psychology